| DESCRIPTION OF ENHANCEMENTS |
VistA Patch PSN*4*304 released November 10, 2011 created a new VA drug
A facility reported that the drug-allergy order check in VistA/CPRS did
not trigger appropriately when a patient was ordered a fluroquinolone type
antibiotic that the patient had a known allergy to. The drug allergy was
properly documented in the VistA Adverse Reaction Tracking (ART) System.
This patch contains a post-install routine that will loop through all the
patient allergies entries for quinolones and will correctly update such
entries with the new class "AM400 QUINOLONES", which should trigger the
drug-allergy order check when the patient is ordered a medication under
this drug class. Once completed, the post-install routine will generate
class "AM400 QUINOLONES". The quinolone antibiotics were previously
and send the Mailman message below to the person who installed the patch,
to the mail group 'NDF DATA' and to all the 'PSNMGR' security key holders.
Subj: Post-install results from patch PSN*4*297 [#110557] 02/02/12
From: NDF MANAGER In 'IN' basket. Page 1
---------------------------------------------------------------------
Number of Patient Allergy entries by class:
Before update:
AM900 - ANTI-INFECTIVES,OTHER: 1601
located under VA drug class "AM900 ANTI-INFECTIVES,OTHER". Existing
AM400 - QUINOLONES : 11
After update:
AM900 - ANTI-INFECTIVES,OTHER: 919
AM400 - QUINOLONES : 693
Enter message action (in IN basket): Ignore//
The results above will vary from site to site. Some sites might even have
the exact same number 'Before' and 'After' the update, which means the
patient allergies in the PATIENT ALLERGIES file (#120.8) to antibiotics
site had not been affected by the problem in PSN*4*304 when it was
installed.
in the quinolone class were not automatically updated to the new VA drug
classification with the release of PSN*4*304. Consequently the entry of
a new order for an antibiotic in the Quinolone VA drug class will not
trigger a drug allergy alert.
|
